secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K/A
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001493152-26-021330
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.95
Item codes: 1.01, 2.01, 2.02, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics completes reverse merger with Applied Digital subsidiary; renames to ChronoScale Corp.
--------------------------------------------------------------------------------

- Applied Parent & Contributor now hold ~97% of outstanding shares; legacy Ekso holders retain ~3%.
- Company issued 138,216,820 new shares to Contributor for 100% of Cloud; post-merger shares outstanding 143,093,381.
- Applied Parent invested $15.75M via PIPE at $12.01/share, receiving 1,311,407 shares.
- Board reconstituted with 4 APLD designees (Wes Cummins as Chairman); ticker changes to 'CHRN' on Nasdaq.
- Fiscal year end changed to May 31; authorized common shares increased to 290M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-021330

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer